We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Biosimilars Guidance Among CDER’s Planned Docs for 2012
New Biosimilars Guidance Among CDER’s Planned Docs for 2012
March 9, 2012
CDER is planning another biosimilars guidance this year that will focus on submitting clinical pharmacology data to show biosimilarity.